Statin safety and associated adverse events: a scientific statement from the American Heart Association

CB Newman, D Preiss, JA Tobert… - … , and vascular biology, 2019 - Am Heart Assoc
One in 4 Americans> 40 years of age takes a statin to reduce the risk of myocardial
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …

Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a …

BS Wiggins, JJ Saseen, RL Page, BN Reed, K Sneed… - Circulation, 2016 - Am Heart Assoc
A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …

[HTML][HTML] National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2

TA Jacobson, KC Maki, CE Orringer, PH Jones… - Journal of clinical …, 2015 - Elsevier
Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)

GBJ Mancini, S Baker, J Bergeron, D Fitchett… - Canadian Journal of …, 2016 - Elsevier
Abstract The Canadian Consensus Working Group has updated its evaluation of the
literature pertaining to statin intolerance and adverse effects. This overview introduces a …

National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report

TA Jacobson, MK Ito, KC Maki, CE Orringer… - Journal of clinical …, 2015 - Elsevier
The leadership of the National Lipid Association convened an Expert Panel to develop a
consensus set of recommendations for patient-centered management of dyslipidemia in …

[HTML][HTML] National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1–executive summary

TA Jacobson, MK Ito, KC Maki, CE Orringer… - Journal of clinical …, 2014 - Elsevier
Various organizations and agencies have issued recommendations for the management of
dyslipidemia. Although many commonalities exist among them, material differences are …

Statin drug interactions and related adverse reactions: an update

S Bellosta, A Corsini - Expert opinion on drug safety, 2018 - Taylor & Francis
Introduction: Statins reduce the risk of cardiovascular morbidity and mortality in patients with
or at risk for cardiovascular disease and their use is expanding, especially in elderly. Statins …

Familial hypercholesterolemia

VE Bouhairie, AC Goldberg - Endocrinology and Metabolism …, 2016 - endo.theclinics.com
Familial hypercholesterolemia (FH) is an inherited condition resulting in high levels of low-
density lipoprotein cholesterol (LDL-C) and increased risk of premature cardiovascular …

[HTML][HTML] Cholesterol lowering drugs

KR Feingold - 2016 - europepmc.org
There are currently eight different classes of drugs available for lowering cholesterol levels.
There are currently seven HMG-CoA reductase inhibitors (statins) approved for lowering …

[HTML][HTML] Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

BA Warden, JR Guyton, AC Kovacs, JA Durham… - Journal of clinical …, 2023 - Elsevier
Statin-associated muscle symptoms (SAMS) are the most common form of statin intolerance
and are associated with increased risk of cardiovascular events that manifest from statin …